Role of Ormeloxifene in Regression of Benign Breast Diseases

International Surgery Journal

doi 10.18203/2349-2902.isj20200816

Full Text

Abstract

Available in

Date

Authors

Publisher

Medip Academy

Related search

Prevalence of Benign Breast Disease and Risk of Malignancy in Benign Breast Diseases

IOSR Journal of Dental and Medical Sciences
2016English

Benign Breast Diseases in North Chennai Women Population

Journal of Evolution of Medical and Dental Sciences
2014English

The Current Scenario of Benign Breast Diseases in Rural India. A Clinicopathological Study

Journal of Evolution of Medical and Dental sciences
2013English

Failure of Leucocyte-Adherence-Inhibition Assays to Discriminate Between Benign and Malignant Breast Diseases

British Journal of Cancer
Cancer ResearchOncology
1979English

ABC of Breast Diseases: Role of Systemic Treatment for Primary Operable Breast Cancer

BMJ
1994English

“The Host’s Role in Hepatocellular Carcinoma Development: A Case of Regression From Probable Malignancy to a Benign Lesion”

Integrative Cancer Science and Therapeutics
2019English

Disparity Expression of Notch1 in Benign and Malignant Colorectal Diseases

PLoS ONE
Multidisciplinary
2013English

Nanoparticle Formulation of Ormeloxifene for Pancreatic Cancer

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2015English

Benign Intracystic Papilloma of the Male Breast

Journal of Ultrasound in Medicine
Nuclear MedicineRadiologyUltrasound TechnologyRadiologicalImagingMedicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy